Tide of capital has gone out
Deborah Sterescu asks Dr Jim Strang, director of fund investments at Dunedin Capital Partners, about today's challenging fundraising climate
More on Fundraising
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
DACH venture and growth deals peak in crisis
Following a strong year in volume terms, market participants remain optimistic about the resilience of the venture ecosystem
Covid-19 impact expected to be more severe than GFC – survey
Almost all Dechert survey respondents expect distressed deals to increase, while 82% cited more deal delays as an ongoing effect
Unquote Private Equity Podcast: Nordic 2020 Review
Katharine Hidalgo welcomes Unquote Nordic reporter Eliza Punshi to discuss how dealflow and fundraising prospects are faring as 2021 rolls on
Latest News
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline